Advantages of PGT at Fairfax Diagnostics

Experience

• Trusted leader in PGT since 1993
• 25 years of PGT assay design & clinical application
• First laboratory in the world to perform PGT-M for an autosomal dominant disease (Marfan syndrome). The first laboratory in the world to achieve a pregnancy following PGT-M for Spinal Muscular Atrophy Type I (SMA-I)
• Staff professionals certified by the American Board of Medical Genetics in Clinical Cytogenetics, Molecular Genetics, and Clinical Genetics
• Expanded team of molecular geneticists
• Staff of board-certified genetic counselors
• CLIA certified high complexity laboratory

Rapid results

• Available to your physician within 2 business days from recipient of samples
• Open 7 days a week, 365 days a year

Molecular Genetic specialists

• Laboratory Director: Brian D. Mariani, PhD
• Medical Director: Harvey J. Stern, MD. PhD, FACMG
• Assistant Laboratory Director: Veronica Novik, PhD
• PGT project lead & assay validation, Khoa Tran, MS
• Our staff of experienced board-certified genetic counselors is also available for support and assistance with the coordination of your PGT cycle

Technology

• PGT-A using NGS by Illumina’s VeriSeq & Blue Fuse data analysis
• PGT-M incorporating 3 levels of resolution:
  • Mutation-specific targeted PCR
  • STR haplotype mapping using PCR & CE
  • Aneupoildy screening using NGS
  • PGT-M assays customized for each couple’s unique genetics
• PGT-SR using NGS as employed for PGT-A
• All PGT approaches can provide gender information for each embryo

Trust

• GIVF maintains a zero misdiagnosis rate in all PGT programs.
• All results reviewed by a team molecular & clinical PhD/MD experts.
• Medical & Laboratory Directors each have over 20 years of experience at Fairfax Dx.
• Genetic Counsellors are involved with all aspects of the PGT program.